LATEST

• BUSINESS CSL Debuts Higher-Dose Hizentra Prefilled Syringe in Japan
  August 3, 2026

• REGULATORY MHLW Names Uchiyama New Pharma Bureau Chief in Senior Shakeup
  August 3, 2026

• ORGANIZATION New Chuikyo Pharmacist Rep Urges 2027 Revision to Stay within 4-Minister Deal
  August 3, 2026

• BUSINESS Taisho Bags Japan Rights to Kaigene’s FcRn Inhibitor KG006
  August 3, 2026

• BUSINESS Datroway Lands EU Approval in 1st-Line TNBC
  August 3, 2026

• BUSINESS Chugai Files Enspryng for MOGAD Relapse Prevention in Japan
  August 3, 2026

• BUSINESS Takeda CEO Says Orzeyful Could Redefine NT1 Standard of Care
  July 31, 2026

• BUSINESS Pfizer Seeks Pediatric Expansion for Hympavzi in Japan
  July 31, 2026

• BUSINESS Nippon Shinyaku Exercises Option for AB2 Bio’s Tadekinig Alfa in US
  July 31, 2026

• ORGANIZATION Ectopic Fat Research Group Launches to Push Cross-Disciplinary Studies
  July 31, 2026

• BUSINESS Alfresa Takes Stake in Ember to Bolster Pharma Cold Chain in Japan
  July 31, 2026

• ORGANIZATION JPMA Chief Seeks Concrete Reforms to Reward Innovation after Honebuto
  July 31, 2026

• ORGANIZATION Patient Groups Launch Consortium to Improve Access to Drug Information
  July 31, 2026

• BUSINESS Sanwa Kagaku Says Kumamoto Plant Remains Shut, Drug Supplies Stable
  July 31, 2026

• REGULATORY Japan to Ease Olanzapine Diabetes Contraindication for Antiemetic Use
  July 31, 2026

• COLUMN Why Your Brain Wants You to Stay (Even When You Want to Go)
  July 31, 2026

• BUSINESS CapEx by 25 Drug Makers in Japan Up 50% Since 2022: Fuji Keizai
  July 31, 2026

• BUSINESS Astellas Expands AI Drug Discovery to TPDs, Engineered Proteins
  July 30, 2026

• BUSINESS Regeneron Japan Files First Dual-AAV Therapy for Genetic Hearing Loss
  July 30, 2026

• BUSINESS Shionogi’s Xocova Debuts in US for COVID-19 PEP
  July 30, 2026

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »